The enoyl-(acyl-carrier protein) (ACP) reductase catalyses the last step in each cycle of fatty acid elongation in the type II fatty acid synthase systems. An extensively characterized NADH-dependent reductase, FabI, is widely distributed in bacteria and plants, whereas the enoyl-ACP reductase, FabK, is a distinctly different member of this enzyme group discovered in Streptococcus pneumoniae. We were unable to delete the fabK gene from Strep. pneumoniae, suggesting that this is the only enoyl-ACP reductase in this organism. The FabK enzyme was purified and the biochemical properties of the reductase were examined. The visible absorption spectrum of the purified protein indicated the presence of a flavin cofactor that was identified as FMN by MS, and was present in a 1:1 molar ratio with protein. FabK specifically required NADH and the protein activity was stimulated by ammonium ions. FabK also exhibited NADH oxidase activity in the absence of substrate. Strep. pneumoniae belongs to the Bacillus/Lactobacillus/Streptococcus group that includes Staphylococcus aureus and Bacillus subtilis. These two organisms also contain FabK-related genes, suggesting that they may also express a FabK-like enoyl-ACP reductase. However, the genes did not complement a fabI(Ts) mutant and the purified flavoproteins were unable to reduce enoyl-ACP in vitro and did not exhibit NAD(P)H oxidase activity, indicating they were not enoyl-ACP reductases. The restricted occurrence of the FabK enoyl-ACP reductase may be related to the role of substrate-independent NADH oxidation in oxygen-dependent anaerobic energy metabolism.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
March 2003
- PDF Icon PDF LinkFront Matter
Research Article|
March 15 2003
Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK)
Hedia MARRAKCHI;
Hedia MARRAKCHI
∗Protein Science Division, Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN 38105, U.S.A.
Search for other works by this author on:
Walter E. DeWOLF, Jr;
Walter E. DeWOLF, Jr
†Department of Assay Methodology & Development, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406, U.S.A.
Search for other works by this author on:
Chad QUINN;
Chad QUINN
‡Department of Physical & Structural Chemistry, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406, U.S.A.
Search for other works by this author on:
Joshua WEST;
Joshua WEST
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
Search for other works by this author on:
Brian J. POLIZZI;
Brian J. POLIZZI
†Department of Assay Methodology & Development, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406, U.S.A.
Search for other works by this author on:
Chi Y. SO;
Chi Y. SO
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
Search for other works by this author on:
David J. HOLMES;
David J. HOLMES
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
Search for other works by this author on:
Shannon L. REED;
Shannon L. REED
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
Search for other works by this author on:
Richard J. HEATH;
Richard J. HEATH
∗Protein Science Division, Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN 38105, U.S.A.
Search for other works by this author on:
David J. PAYNE;
David J. PAYNE
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
Search for other works by this author on:
Charles O. ROCK;
Charles O. ROCK
∗Protein Science Division, Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN 38105, U.S.A.
∥Department of Molecular Biosciences, University of Tennessee Health Science Center, Memphis, TN 38163, U.S.A.
Search for other works by this author on:
Nicola G. WALLIS
Nicola G. WALLIS
1
§Department of Anti-infective Research, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, U.S.A.
1To whom correspondence should be addressed. Present address: Astex-Technology, 436 Cambridge Science Park, Milton Rd, Cambridge CB4 0QA, U.K. (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 31 2002
Revision Received:
December 16 2002
Accepted:
December 18 2002
Accepted Manuscript online:
March 15 2003
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2003
2003
Biochem J (2003) 370 (3): 1055–1062.
Article history
Received:
October 31 2002
Revision Received:
December 16 2002
Accepted:
December 18 2002
Accepted Manuscript online:
March 15 2003
Citation
Hedia MARRAKCHI, Walter E. DeWOLF, Chad QUINN, Joshua WEST, Brian J. POLIZZI, Chi Y. SO, David J. HOLMES, Shannon L. REED, Richard J. HEATH, David J. PAYNE, Charles O. ROCK, Nicola G. WALLIS; Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). Biochem J 15 March 2003; 370 (3): 1055–1062. doi: https://doi.org/10.1042/bj20021699
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |